Individuals with HIV who were resistant to all four antiretroviral drug classes experienced higher mortality than those who were not resistant, a difference primarily due to lower CD4 cell counts.
The US Food and Drug Administration (FDA) on Thursday issued a final order classifying next generation sequencing (NGS) HIV drug resistance genotyping assays used to aid in monitoring and treating HIV ...
The U.S. Food and Drug Administration on April 21, 2026, approved Merck’s Idvynso, a once-daily combination pill for HIV treatment that pairs two drug classes in a single tablet. The approval gives ...
HIV-1 drug resistance emerges when mutations in viral enzymes reduce the binding or efficacy of antiretroviral agents, undermining therapy and enabling transmission of resistant strains. Resistance ...
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV's spread among ...
HIV treatment has progressed significantly since the 1980s. ART enables viral suppression and prevents transmission, but HIV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results